| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.159.10.1104 |
| P698 | PubMed publication ID | 10335688 |
| P50 | author | William B. Kannel | Q15439387 |
| Ralph B. D'Agostino Sr. | Q59209521 | ||
| Peter Wilson | Q89854449 | ||
| P2093 | author name string | H Silbershatz | |
| P433 | issue | 10 | |
| P921 | main subject | coronary artery disease | Q844935 |
| heart disease | Q190805 | ||
| P304 | page(s) | 1104-1109 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Clustering of metabolic factors and coronary heart disease | |
| P478 | volume | 159 |
| Q36402808 | 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice |
| Q21284500 | A comprehensive review on metabolic syndrome |
| Q39755140 | A rural-urban comparison of the characteristics of the metabolic syndrome by gender in Korea: the Korean Health and Genome Study (KHGS). |
| Q26776259 | A systematic review on the association of serum selenium and metabolic syndrome |
| Q57388730 | Abdominal Fat and Risk of Coronary Heart Disease in Patients with Peripheral Arterial Disease* |
| Q37304801 | Abnormal cardiac structure and function in the metabolic syndrome: a population-based study |
| Q36085772 | Accumulation of metabolic cardiovascular risk factors in black and white young adults over 20 years |
| Q89380489 | Alterations in cellular lipid metabolism produce neutral lipid accumulation following exposure to the organochlorine compound trans-nonachlor in rat primary hepatocytes |
| Q36055347 | Applying the Framingham risk score for prediction of metabolic syndrome: The Kerman Coronary Artery Disease Risk Study, Iran |
| Q46570966 | Association among metabolic syndrome, testosterone level and severity of erectile dysfunction. |
| Q40958648 | Association of Changes in Neck Circumference with Cardiometabolic Risk in Postmenopausal Healthy Women |
| Q46751800 | Association of hypoadiponectinemia with metabolic syndrome in patients with polycystic ovary syndrome. |
| Q33781951 | Association of plasma retinol-binding protein 4, adiponectin, and high molecular weight adiponectin with insulin resistance in non-diabetic hypertensive patients |
| Q92341034 | Association of predicted 10 years cardiovascular mortality risk with duration of HIV infection and antiretroviral therapy among HIV-infected individuals in Durban, South Africa |
| Q51479700 | Association of the metabolic syndrome with vascular disease in an older Chinese population: Guangzhou Biobank Cohort Study. |
| Q79216181 | Associations between aortic calcification and components of body composition in elderly men |
| Q34404827 | Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering |
| Q37306225 | Body size and renal cell cancer incidence in a large US cohort study |
| Q37159095 | Cardiometabolic risk: a Framingham perspective |
| Q30743765 | Cardiovascular Disease in Women: Clinical Perspectives |
| Q92548798 | Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis |
| Q37136649 | Cardiovascular disease risk factor clustering among African American adults |
| Q37151925 | Cardiovascular high-risk patients--treat to protect, but whom? |
| Q36842413 | Changes in body weight predict CKD in healthy men. |
| Q26784618 | Clinical characteristics of metabolic syndrome in Korea, and its comparison with other Asian countries |
| Q90954032 | Cluster patterns of behavioural risk factors among children: Longitudinal associations with adult cardio-metabolic risk factors |
| Q64119557 | Clustering of cardiovascular disease biological risk factors among older adults in Shenzhen City, China: a cross-sectional study |
| Q40002598 | Comparison of photoplethysmographic and arterial tonometry-derived indices of arterial stiffness |
| Q45147749 | Cooccurrence of lifestyle risk factors and the explanation of education inequalities in mortality: results from the GLOBE study |
| Q55263145 | Coronary Disease and Metabolic Syndrome. |
| Q80567766 | Determinants of the intima-media thickness in children and adolescents with chronic kidney disease |
| Q37809444 | Does Nurse Case Management Improve Implementation of Guidelines for Cardiovascular Disease Risk Reduction? |
| Q83450944 | Does the metabolic syndrome carry additional risk for myocardial infarction? |
| Q37643653 | Effect of Helicobacter pylori on metabolic syndrome parameters in diabetic patients |
| Q86093853 | Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status |
| Q36610967 | Effect of workplace-visiting nutrition education on anthropometric and clinical measures in male workers |
| Q91816753 | Effectiveness and Characterization of Severely Energy-Restricted Diets in People with Class III Obesity: Systematic Review and Meta-Analysis |
| Q42701227 | Effects of self-paced interval and continuous training on health markers in women |
| Q36916772 | Elderly women with metabolic syndrome present higher cardiovascular risk and lower relative muscle strength. |
| Q51938302 | Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes. |
| Q35087486 | Epidemiology of the insulin resistance syndrome |
| Q34016157 | Epidemiology of type 2 diabetes and cardiovascular disease: translation from population to prevention: the Kelly West award lecture 2009. |
| Q51369576 | Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects. |
| Q36590822 | Expanding the definition of hypertension to incorporate global cardiovascular risk |
| Q45983621 | Factor analysis of metabolic syndrome components in severely obese girls and boys. |
| Q34462148 | Factor structure underlying components of allostatic load |
| Q47232556 | Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities |
| Q33653585 | First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX) |
| Q40576547 | Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure. |
| Q36441958 | Gender differences in the metabolic syndrome and their role for cardiovascular disease. |
| Q34374343 | Glycemic Control and Weight Reduction Without Causing Hypoglycemia: The Case for Continued Safe Aggressive Care of Patients With Type 2 Diabetes Mellitus and Avoidance of Therapeutic Inertia |
| Q35118909 | HIV and general cardiovascular risk |
| Q57466987 | Hormone Replacement Therapy: Would it be Possible to Replicate a Functional Ovary? |
| Q73069687 | How deadly is the "deadly quartet"? A post-CABG evaluation |
| Q34327231 | Hyperglycemia and cardiovascular disease |
| Q34990490 | Hypertension and lipids: lipid factors in the hypertension syndrome |
| Q37879655 | Hypertension in postmenopausal women: pathophysiology and treatment |
| Q37657406 | Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease. |
| Q33505849 | Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records |
| Q34224453 | Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project |
| Q45152352 | Impact of metabolic syndrome in the control of blood pressure and dyslipemia |
| Q37045342 | Impact of metabolic syndrome on the progression of coronary calcium and of coronary artery disease assessed by repeated cardiac computed tomography scans. |
| Q37295171 | Impact of the metabolic syndrome on aortic pulse pressure and ascending aortic pulsatility in patients with angiographically normal coronary arteries |
| Q31140498 | Increasing trend of diabetes combined with hypertension or hypercholesterolemia: NHANES data analysis 1999-2012 |
| Q37161855 | Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women |
| Q36738578 | Inflammatory status in older women with and without metabolic syndrome: is there a correlation with risk factors? |
| Q36860517 | Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease |
| Q73409249 | Influence of leisure time physical activity and television watching on atherosclerosis risk factors in the NHLBI Family Heart Study |
| Q43978040 | Insulin resistance and hypertension in postmenopausal women |
| Q43201477 | Is it the resistance training itself or the combined associated weight loss that improves the metabolic syndrome-related phenotypes in postmenopausal women? |
| Q37604621 | Is there a link between polycystic ovary syndrome and non-thyroidal illness syndrome? |
| Q34682870 | Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology |
| Q57289186 | Levels of adherence needed to achieve significant weight loss |
| Q93926319 | Lipodystrophy in HIV-1-infected patients |
| Q37795877 | Liraglutide: effects beyond glycaemic control in diabetes treatment |
| Q47689493 | Long-term care in developed countries and recommendations for Slovak Republic |
| Q49078734 | Long-term results of a prospective study on laparoscopic adjustable gastric banding for morbid obesity |
| Q79198922 | Longitudinal changes in risk variables underlying metabolic Syndrome X from childhood to young adulthood in female subjects with a history of early menarche: The Bogalusa Heart Study |
| Q38389493 | MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose SM vs. Medical Therapy |
| Q35574560 | Management of diabetes across the course of disease: minimizing obesity-associated complications |
| Q36394361 | Managing cardiovascular risk inpatients with metabolic syndrome |
| Q46441808 | Maternal Attitudes and Behaviors Regarding Feeding Practices in Elementary School-Aged Latino Children: A Pilot Qualitative Study on the Impact of the Cultural Role of Mothers in the US-Mexican Border Region of San Diego, California. |
| Q37573664 | Maternal attitudes and behaviors regarding feeding practices in elementary school-aged Latino children: a pilot qualitative study on the impact of the cultural role of mothers in the US-Mexican border region of San Diego, California. |
| Q36181734 | Menopause versus aging: The predictor of obesity and metabolic aberrations among menopausal women of Karnataka, South India |
| Q35149077 | Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction |
| Q35750418 | Metabolic syndrome among adults in New York City, 2004 New York City Health and Nutrition Examination Survey |
| Q35890114 | Metabolic syndrome among obese Qataris attending primary health care centers in Doha, 2010. |
| Q44871514 | Metabolic syndrome and incident coronary heart disease in Australian indigenous populations |
| Q37414458 | Metabolic syndrome and insulin resistance in Division 1 collegiate football players |
| Q37179191 | Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study |
| Q42757693 | Metabolic syndrome and urologic diseases |
| Q33607601 | Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness |
| Q37003941 | Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). |
| Q37388985 | Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study |
| Q36405158 | Metabolic syndrome: a marker of patients at high cardiovascular risk |
| Q36477959 | Metabolic syndrome: do clinical criteria identify similar individuals among overweight premenopausal women? |
| Q36476281 | Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome |
| Q35187308 | Multiple biomarker models for improved risk estimation of specific cardiovascular diseases related to metabolic syndrome: a cross-sectional study. |
| Q93047473 | Obesity as the Main Risk Factor for Metabolic Syndrome in Children |
| Q61775731 | Obesity in Older Adults: Technical Review and Position Statement of the American Society for Nutrition and NAASO, The Obesity Society |
| Q79183317 | Orlistat in the treatment of obesity |
| Q34438273 | Outcome success in obesity |
| Q36265716 | Oxidative stress in metabolic syndrome |
| Q34438251 | Physician involvement in the management of obesity as a primary medical condition |
| Q37561145 | Prevalence and incident prehypertension and hypertension in postmenopausal Hispanic women: results from the Women's Health Initiative |
| Q36729200 | Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom |
| Q36537512 | Prevalence of Metabolic Syndrome and its Related Risk Factors in the City of Oran, Algeria: the ISOR Study |
| Q51497305 | Prevalence of erectile dysfunction in patients with metabolic syndrome. |
| Q89661646 | Prevalence of high-risk coronary plaques in patients with and without metabolic syndrome and the relationship with prognosis |
| Q50989763 | Prevalence of metabolic syndrome among college football linemen. |
| Q45941296 | Prevalence of self-reported cardiovascular risk factors in Portuguese women: a survey after delivery. |
| Q33654688 | Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea |
| Q47367487 | Prevalence, treatment patterns and control rates of metabolic syndrome in a Chinese diabetic population: China Cardiometabolic Registries 3B study |
| Q44727708 | Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. |
| Q80164196 | Preventing vascular events in high-risk patients: primary care on the front line |
| Q34140730 | Primary prevention of heart disease in women |
| Q36905627 | Protective cardiovascular and renal actions of vitamin D and estrogen |
| Q62113217 | Pulse hypertension: a new component of the metabolic syndrome in elderly women? |
| Q37107163 | Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study |
| Q34005096 | Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. |
| Q30356450 | Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. |
| Q37801531 | Review of Cardiometabolic Risk Factors Among Current Professional Football and Professional Baseball Players |
| Q36901478 | Risk profiles for metabolic syndrome in a nonclinical sample of adolescent girls |
| Q44160580 | Risk stratification of obesity as a coronary risk factor |
| Q36160323 | Serum antioxidant concentrations and metabolic syndrome are associated among U.S. adolescents in recent national surveys |
| Q34802116 | Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys |
| Q22306384 | Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure |
| Q91660762 | Sex differences in the association of metabolic syndrome with low back pain among middle-aged Japanese adults: a large-scale cross-sectional study |
| Q37131008 | Sex may modify the effects of macronutrient intake on metabolic syndrome and insulin resistance in American Indians: the strong heart study |
| Q37761679 | Statins as adjunctive therapy in the management of hypertension |
| Q86838757 | Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study |
| Q38553529 | Targeting inflammation in metabolic syndrome. |
| Q34804715 | Task force #1--magnitude of the prevention problem: opportunities and challenges. 33rd Bethesda Conference |
| Q46587223 | Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population |
| Q36319159 | The definition of weight maintenance |
| Q73904927 | The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial |
| Q37635560 | The factor structure of the metabolic syndrome in obese individuals with binge eating disorder |
| Q37472918 | The future of obesity reduction: beyond weight loss |
| Q35765179 | The global epidemic of obesity: are we becoming more sympathetic? |
| Q35015945 | The kaiser permanente northwest cardiovascular risk factor management program: a model for all. |
| Q40810438 | The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndrome |
| Q73652376 | The metabolic syndrome |
| Q40582016 | The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey |
| Q36459414 | The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care |
| Q53939137 | The metabolic syndrome as a vicious cycle: does obesity beget obesity? |
| Q35827751 | The metabolic syndrome in China |
| Q36102167 | The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration |
| Q44597940 | The metabolic syndrome: a critical appraisal based on the CUORE epidemiologic study |
| Q35135723 | The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. |
| Q27003277 | The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance |
| Q51366851 | The whey fermentation product malleable protein matrix decreases TAG concentrations in patients with the metabolic syndrome: a randomised placebo-controlled trial. |
| Q80568631 | Treatment patterns of hypertension and dyslipidaemia in hypertensive patients at higher and lower risk of cardiovascular disease in primary care in the United Kingdom |
| Q34129723 | Understanding the metabolic syndrome: a modeling perspective |
| Q53135887 | Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial. |
| Q36213947 | Vodka and wine consumption in a swine model of metabolic syndrome alters insulin signaling pathways in the liver and skeletal muscle |
| Q36756117 | Warm Parenting Associated with Decreasing or Stable Child BMI during Treatment |
| Q28088815 | Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences |
| Q39030270 | Weight Management in Primary Care |
| Q47397562 | Weight loss: a tool to reduce proteinuria |
| Q35780390 | What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome |
Search more.